Anti-SARS-CoV-2 Spike S1 (RBD) Neutralizing Antibody (V3S-0623-XY39) (CAT#: V3S-0623-XY39)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description The antibody 910-30 is a human mAb specific for SARS-CoV-2 Spike S1 protein. It has moderate neutralization capacity. It showed an IC50 of 0.071 μg/mL against a vesicular stomatitis virus SARS-CoV-2 pseudovirus and 0.142 μg/mL against authentic SARS-CoV-2. It recognized a glycan-independent epitope.
Clonality Monoclonal
Host Species Human
Target Species SARS-CoV-2
Epitope Recognized a glycan-independent epitope
Isotype IgG1

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application ELISA, Neut
Application Notes S trimer and RBD ELISAs were performed in triplicate. 175 ng of antigen per well was coated onto 96-well ELISA plates at 4°C overnight. Plates were washed and then blocked with 100 μL of blocking buffer at 37°C for 2 hr. Purified antibodies were serial diluted using dilution buffer, added to the antigen-coated blocked plates, and then incubated at 4°C for 1 hr. Plates were washed and 50 μL of a secondary anti-human kappa light chain detection antibody was added to each well and incubated at room temperature for 1 hr. After the final wash, 50 μL TMB substrate was used to detect antibody binding to antigen measuring absorbance at 405 nm. The antibody 910-30 showed an IC50 of 0.071 μg/mL against a vesicular stomatitis virus SARS-CoV-2 pseudovirus and 0.142 μg/mL against authentic SARS-CoV-2.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Western Blot Protocol

Target

Target SARS-CoV-2
Alternative Name Severe acute respiratory syndrome coronavirus 2
Research Area Coronavirus Disease 2019
Related Disease Coronavirus Disease 2019
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry